Hologic Announces Innovative Collaboration with AAGL and Inovus Medical to Optimize OB-GYN Training for Minimally Invasive Surgeries
10 Outubro 2023 - 9:30AM
Business Wire
Partnership to Include Integration of Hologic
Products, Specifically Designed for Gynecologic Care, into Hands-On
Skills Education for OB-GYN Residents
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health,
today announced an innovative new partnership with the American
Association of Gynecologic Laparoscopists (AAGL) and Inovus
Medical. Hologic becomes the chief provider of hysteroscopes for
AAGL’s Essentials in Minimally Invasive Gynecologic Surgery (EMIGS)
hands-on hysteroscopy skills training for OB-GYN residents.
“At Hologic, we believe high-quality medical education can
inspire positive change. Women’s health technology has
significantly improved over the years, but current training options
have not taken these advancements into consideration. Through this
innovative partnership, we aim to elevate minimally invasive
gynecologic surgical training and improve women’s healthcare by
educating future OB-GYNs on newer treatment options for common
gynecologic conditions,” said Essex Mitchell, President of
Hologic’s Gynecologic Surgical Solutions Division.
AAGL, the premier global association in minimally invasive
gynecologic surgery, began offering the EMIGS-validated training
and testing program in 2022 to provide a gynecology-specific
cognitive and skills test that allows OB-GYN residents to meet the
Surgical Skills Program Standard for the American Board of
Obstetrics and Gynecology examination. AAGL contracts with Inovus
Medical, an award-winning designer and manufacturer of surgical
training technologies, for the manufacturing and delivery of the
hands-on training equipment for EMIGS.
Though not all residents will become minimally invasive
gynecologic surgeons, nearly all will care for patients as
practicing OB-GYNs. Considering that one in three women will suffer
from abnormal uterine bleeding (AUB) in their lifetime1 and up to
77% of women will develop uterine fibroids during their
childbearing years,2 Hologic aspires for every OB-GYN to know of
all treatment options available for common gynecologic conditions,
including laparoscopic and hysteroscopic solutions.
“Our collaboration with Hologic and Inovus provides the vital
infrastructure needed to bring EMIGS to life,” said Linda Michels,
AAGL Executive Director. “This will allow us to provide equitable
access to high-quality, hands-on training tools to future
OB-GYNs.”
In addition to providing one Omni® hysteroscope to all
Accreditation Council for Graduate Medical Education-approved
residency programs, Hologic will loan one LapAR® and one HystAR® to
all sites, as well as support software licensing that will power
Inovus’ connected training platform, Totum®. As part of the
partnership, residents will also have the opportunity to train with
Hologic’s gynecologic surgical tools.
“We’re excited to welcome Hologic into this partnership and
integrate their Omni hysteroscopes into our surgical training
technology and are confident the collaboration will further elevate
EMIGS training in a meaningful way,” said Elliot Street, M.D.,
Co-Founder and CEO of Inovus Medical.
“This collaboration will strengthen our ability to offer
hysteroscopy simulation for our residents, and to integrate
advanced tools to aid our trainees in pursuing excellence in
surgical training,” said Nash S. Moawad, M.D., EMIGS Chair.
Learn more about EMIGS at www.aagl.org/emigs/.
About Hologic, Inc.
Hologic, Inc. is a global medical technology innovator focused
on improving the health and well-being of women, their families and
communities through early detection and treatment. Its advancements
include invention of the world’s first commercial 3D mammography
system to find breast cancer earlier; leadership in testing for
cervical cancer, sexually transmitted infections and respiratory
illnesses; and minimally invasive surgical technologies for uterine
fibroids, abnormal uterine bleeding and pediatric procedures.
Hologic, The Science of Sure and Omni are trademarks and/or
registered trademarks of Hologic, Inc. and/or its subsidiaries in
the United States and/or other countries.
Learn more at GynSurgicalSolutions.com.
About AAGL
AAGL is a professional medical association of endoscopic
surgeons and is the global leader in minimally invasive gynecologic
surgery. AAGL’s mission is to elevate the quality and safety of
health care for women through excellence in clinical practice,
education, research, innovation and advocacy. Find out more about
the AAGL at: www.aagl.org.
About Inovus Medical
Inovus Medical is a multi-award-winning designer and
manufacturer of surgical training technologies based in St Helens,
U.K. The company was founded in 2012 with a clear purpose: to
improve surgical care through connected training. At the heart of
everything Inovus does are its core values of affordable,
accessible and functional technologies. Learn more about Inovus
Medical at: www.inovus.org.
Forward-Looking Statements
This news release may contain forward-looking information that
involves risks and uncertainties, including statements about the
use of Hologic products. There can be no assurance these products
will achieve the benefits described herein or that such benefits
will be replicated in any particular manner with respect to an
individual patient, as the actual effect of the use of the products
can only be determined on a case-by-case basis. In addition, there
can be no assurance that these products will be commercially
successful or achieve any expected level of sales. Hologic
expressly disclaims any obligation or undertaking to release
publicly any updates or revisions to any such statements presented
herein to reflect any change in expectations or any change in
events, conditions or circumstances on which any such data or
statements are based.
Source: Hologic, Inc.
1 NIH National Library of Medicine,
https://www.ncbi.nlm.nih.gov/books/NBK532913. Accessed September
20, 2022 2
https://www.hopkinsmedicine.org/health/conditions-and-diseases/uterine-fibroids.
Accessed February 20, 2019
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231010890153/en/
Media Contact: Bridget Perry Director, Corporate
Communications +1 508.263.8654 bridget.perry@hologic.com
Investor Contact: Ryan Simon Vice President, Investor
Relations +1 858.410.8514 ryan.simon@hologic.com
Hologic (NASDAQ:HOLX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Hologic (NASDAQ:HOLX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024